Overview
Chemicals

NICHIBAN CO.,LTD.

Nichiban Co., Ltd. is a Japanese manufacturer specializing in pressure-sensitive adhesive tapes and related products, leveraging proprietary adhesive and polymer technologies across fabric, paper, cellophane, and plastic substrates. The company serves three primary segments: Medical (bandages, wound care tapes, and medical adhesive products), Industrial Tape (construction and industrial-use adhesive tapes), and Stationery (cellophane tape and office adhesive products). Key brands include the iconic Sellotape (Celotape®) and Battlewin™ sports taping products, sold through domestic manufacturing and international subsidiaries covering Southeast Asia, South Asia, the Middle East, and Europe.

Market Cap
¥38.0B
US$242M
EV
¥23.2B
US$148M
Stock¥1,882▲+0.21%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
4.6
x
LTM EV/EBIT
10.4
x
LTM PER
23.0
x
LTM PBR
0.9
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-24.5%pt
100
Oct 24, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
38.0BUS$242MMarket Cap1.17BUS$7.47M+ Debt13.2BUS$84.2M− Cash2.75BUS$17.6M− Inv. Sec.23.2BUS$148MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
43.1US$275M'22/345.6US$291M'23/346.9US$299M'24/349.5US$315M'25/350.5US$322M'26/3
EBITDA 5Y (¥B)
5.00US$31.9M'22/34.37US$27.8M'23/34.87US$31.0M'24/35.73US$36.5M'25/35.11US$32.6M'26/3
Net Income 5Y (¥B)
1.81US$11.5M'22/32.37US$15.1M'23/31.83US$11.7M'24/31.96US$12.5M'25/31.65US$10.5M'26/3
Capital Structure
97%
EquityD/E 0.03xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
16.7US$106M2.15US$13.7M'22/317.6US$112M2.14US$13.7M'23/316.2US$103M2.13US$13.6M'24/317.6US$112M2.12US$13.5M'25/316.5US$105M2.17US$13.8M'26/3
Shareholders
Top 10 hold 63.4%
1
Taiho Pharmaceutical Co., Ltd.
33.49%
2
The Master Trust Bank of Japan, Ltd. (Trust Account)
6.81%
3
NICHIBAN CO.,LTD. Business Partners' Stock Ownership Association
5.89%
4
MUFG Bank, Ltd.
3.96%
5
Mizuho Bank, Ltd.
3.96%
6
STATE STREET BANK AND TRUST COMPANY 505103 (Standing Proxy: Mizuho Bank, Ltd.)
3.38%
7
Aioi Nissay Dowa Insurance Co., Ltd.
1.87%
8
Resona Bank, Limited
1.43%
9
NORTHERN TRUST CO.(AVFC) RE IEDP AIF CLIENTS NON TREATY ACCOUNT (Standing Proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)
1.33%
10
NICHIBAN CO.,LTD. Employee Stock Ownership Association
1.33%
Management
10 officers
Toshiaki TAKATSU
Representative Director, President
Apr 1990 Joined the Company Jun 2015 General Manager, Purchasing Department, Business Management Division Apr 2017 General Manager, Central Japan Sales Department, Industrial Products Sales Division Apr 2018 Executive Officer, General Manager, Medical Special Sales Department Apr 2019 Senior Executive Officer, Assistant to the President Jun 2019 Representative Director, President (current)
1966-11-13
Hiroki SAKAI
Senior Managing Director
Apr 1985 Joined the Company Apr 2008 Executive Officer, General Manager, Administration Department Jun 2009 Director, Executive Officer, General Manager, Administration Department Jun 2015 Managing Director, in charge of CSR and Management Planning Oct 2016 Managing Director, in charge of CSR and Management Planning; Director and Advisor in charge of Management, Daito Kako Co., Ltd. (concurrently) Jun 2019 Senior Managing Director, in charge of Promotion Unit and CSR; General Manager, Public Relations and Advertising Office (concurrently) Apr 2020 Senior Managing Director (current)
1961-07-06
Yasuhiko TAKAHASHI
Director, Managing Executive Officer, General Manager, Corporate Planning Office
Apr 1986 Joined the Company Apr 2011 Executive Officer, General Manager, Anjo Plant Jun 2013 Representative Director, President, Nichiban Techno Co., Ltd. Apr 2016 Senior Executive Officer, General Manager, Administration Division Apr 2020 Managing Executive Officer, General Manager, Corporate Planning Office; General Manager, Public Relations and Advertising Department (concurrently) Jun 2021 Director, Managing Executive Officer, General Manager, Corporate Planning Office (current)
1963-01-09
Osamu SAKAMOTO
Full-time Audit and Supervisory Board Member
Apr 1990 Joined the Company Apr 2020 General Manager, Internal Audit Office Apr 2022 Executive Officer, General Manager, General Affairs Department, Administration Division; in charge of Internal Control (concurrently) Apr 2024 Executive Officer, assigned to Audit and Supervisory Board Jun 2024 Audit and Supervisory Board Member (current)
1968-01-30
Tatsuo ISHIHARA
Director
Oct 1977 Passed National Bar Examination Apr 1980 Appointed Public Prosecutor, Tokyo District Public Prosecutors Office Apr 1987 Registered as Attorney at Law Jan 1989 Opened Okishin Ishihara Law Office (renamed Spring Law Office); Representative (current) Jun 2016 Outside Director of the Company (current)
1952-03-01
Akihiro SATO
Director
Oct 1987 Passed National Bar Examination Apr 1990 Registered as Attorney at Law Apr 1990 Joined Marunouchi Kyoritsu Law Office May 1995 Opened Akihiro Sato Law Office; Representative Dec 2016 Outside Audit and Supervisory Board Member of the Company Jun 2019 Outside Director of the Company (current) Jun 2023 Partner, Shinwa Sogo Law Offices (current)
1959-06-25
Hiromi SANADA
Director
Apr 1979 Nurse, Internal Medicine Ward, St. Luke's International Hospital Apr 1980 Nurse, Surgical Ward, Kanazawa University Hospital Apr 1981 Assistant, Department of Nursing, Kanazawa University College of Medical Technology; later Associate Professor Apr 1987 Research Student, Kanazawa University School of Medicine Apr 1989 Graduate Program (training), University of Illinois College of Nursing, USA (until Mar 1990) Mar 1997 Doctor of Medical Science, Kanazawa University Nov 1998 Professor, Department of Health Sciences, Kanazawa University School of Medicine Apr 2004 Graduate School of Medicine, University of Tokyo, Department of Health Sciences and Nursing Apr 2017 Director, Center for Global Nursing Research, Graduate School of Medicine, University of Tokyo Apr 2022 President, Ishikawa Prefectural Nursing University (current) Jun 2022 Professor Emeritus, University of Tokyo (current) Jun 2022 Outside Director of the Company (current)
1956-05-20
Junko SUGAWARA
Director
Apr 1983 Joined Calpis Food Industry Co., Ltd. (now Calpis Co., Ltd.) Apr 2014 General Manager, Milk Procurement Department, Calpis Co., Ltd.; Outside Director, Calpis Food Service Co., Ltd. Mar 2018 Director, Calpis Co., Ltd. Mar 2021 Representative Director, President, Calpis Co., Ltd. Jun 2025 Outside Director of the Company (current)
1962-04-26
Yasushi KODAMA
Audit and Supervisory Board Member
Oct 1988 Passed National Bar Examination Apr 1991 Physician, U.S. Naval Hospital Yokosuka, Japan May 1991 Passed National Medical Licensing Examination Apr 1992 Trainee, Legal Training and Research Institute of the Supreme Court of Japan Apr 1994 Joined Hasegawa Toshiaki Law Office Sep 1995 Joined Sidley & Austin (Chicago) Aug 1996 Joined Barlow Lyde & Gilbert (London) Nov 1996 Passed New York State Bar Examination Jun 2004 Specially Appointed Professor, Graduate School of Medicine, University of Tokyo Apr 2012 Opened Shinsei Sogo Law Office; Representative (current) Jun 2019 Outside Audit and Supervisory Board Member of the Company (current) Jul 2025 Auditor, Tokyo Medical University (current)
1958-05-06
Atsushi FUKUDA
Audit and Supervisory Board Member
Oct 1985 Joined Asahi Shinwa Accounting Firm (now KPMG AZSA LLC) Apr 1989 Registered as Certified Public Accountant May 2006 Senior Partner, KPMG AZSA LLC (now Partner) Jun 2021 Retired from KPMG AZSA LLC Jun 2022 Outside Audit and Supervisory Board Member of the Company (current) May 2024 Auditor, Saitama Medical University (current)
1959-01-24
Large Shareholding Reports
Mizuho Bank, Ltd.
2026-03-23
4.82%→3.86%
Annual report (as of 2026-03-31): 3.96%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-08-10
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-23
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-03-23
Large Shareholding Report
TDnet
2026-02-10
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-13
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-24
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-10
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-12
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-08
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-26
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-13
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-28
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-10
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-10
Quarterly Securities Report
EDINET
2022-08-10
Quarterly Securities Report
EDINET
2022-06-28
Annual Securities Report
EDINET
2022-02-10
Quarterly Securities Report
EDINET
2021-11-10
Quarterly Securities Report
EDINET
2021-08-13
Quarterly Securities Report
EDINET
2021-06-25
Annual Securities Report
EDINET
2021-02-10
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →